Piramal Pharma Limited
Nifty 500
Smallcap 50
Smallcap 100
Smallcap 250
₹211.50
-0.47%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.7.
- Pays a dividend (yield about 0.07%).
- Promoters hold a sizeable stake (34.8%).
!Watch-points
- Return on equity is on the lower side at -3.8%.
- Return on capital employed is on the lower side at 2.5%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.18
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the working-capital term (current-asset split not available for this stock).
Piotroski F-ScoreWeak
2 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap₹ 28,024 Cr
Current Price₹ 211.50
High / Low₹ 231.93 / 132.30
Stock P/E—
Book Value₹ 61.40
Dividend Yield0%
ROCE2.52%
ROE-3.83%
Face Value₹ 10.00
Debt to Equity0.70
PEG Ratio—
EV / EBITDA19.29
Industry PE35.70
P/B Ratio3.4388006
EPS₹ -2.45
Debt₹ 5,675 Cr
PAT Margin-3.68%
Cash PAT₹ 505 Cr
ICR2.70
Promoter Holding34.80%
FII Holding12.51%
DII Holding14.57%
Public Holding37.62%
Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity